Publication | Closed Access

Omega-3 fatty acids and blood-based biomarkers in Alzheimer’s disease and mild cognitive impairment: A randomized placebo-controlled trial

Neurodegenerative DiseasesAlzheimer's DiseaseOmega-3 Fatty AcidMedicineBlood-based BiomarkersBiomarkersNeurochemical BiomarkersNeuroscienceNeurologyMild Cognitive ImpairmentAging-associated DiseaseOmega-3 Fatty AcidsRisk Factors